跳至主要内容
临床试验/NCT06993220
NCT06993220招募中不适用

Multiparametric Assessment of Residual Congestion at Discharge in Patients With Acute Heart Failure

Consorci Sanitari Integral1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2025年1月1日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
500
试验地点
1
主要终点
Worsening heart failure or cardiovascular death

研究概览

简要总结

Treatment of congestion is one of the main goals in patients hospitalized for acute heart failure. Nevertheless, current evidence shows that decongestion is often not achieved and that residual congestion at discharge is strongly associated with poor outcomes. While this association has been demonstrated, previous studies have primarily focused on single parameters of congestion (physical examination, biomarkers, or imaging features). The aim of the study is to assess residual congestion at discharge using a multiparametric approach and to compare the prognostic value of each evaluation strategy. Additionally, the analysis will be supported by artificial intelligence to develop a multiparametric prognostic algorithm that can provide an improved predictive model compared to standard statistical approaches.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years.
  • Patients hospitalized for new onset heart failure or worsening heart failure defined by:
  • Symptoms classified as New York Heart Association class III or IV.
  • Clinical or instrumental signs of volume overload (e.g., dyspnea with evidence of pulmonary congestion on X-rays or lung ultrasound, pitting edema, and jugular venous distension).
  • Elevated NT-proBNP levels within the first 24 hours of admission (cutoff values: 450 ng/L for patients < 50 years; >900 ng/L for patients aged 50-75 years; >1800 ng/L for patients >75 years).
  • Ability to provide informed consent.

排除标准

  • Known diagnosis of septicemia.
  • Glomerular filtration rate < 15 ml/min.
  • Life expectancy < 6 months.
  • Active myocarditis.
  • Heart transplant recipients.
  • Patients with ventricular assist devices.
  • Congenital heart diseases.
  • Moderate-to-severe liver disease (Child-Pugh B-C).
  • Patients that will not be followed up by the Heart Failure Unit.

结局指标

主要结局

Worsening heart failure or cardiovascular death

时间窗: 6 months after hospital discharge

Occurrence of the composite of cardiovascular death and worsening heart failure (defined as unplanned hospitalization or urgent visit resulting in diuretic intravenous therapy)

次要结局

  • all-cause death(6 months after hospital discharge)
  • time to first heart failure event(6 months after hospital discharge)
  • number of heart failure events(6 months after hospital discharge)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验